Annual Current Assets
$212.60 M
+$2.14 M+1.02%
December 31, 2023
Summary
- As of February 8, 2025, ORIC annual total current assets is $212.60 million, with the most recent change of +$2.14 million (+1.02%) on December 31, 2023.
- During the last 3 years, ORIC annual current assets has fallen by -$84.10 million (-28.35%).
- ORIC annual current assets is now -28.35% below its all-time high of $296.70 million, reached on December 31, 2020.
Performance
ORIC Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$279.43 M
-$15.17 M-5.15%
September 30, 2024
Summary
- As of February 8, 2025, ORIC quarterly total current assets is $279.43 million, with the most recent change of -$15.17 million (-5.15%) on September 30, 2024.
- Over the past year, ORIC quarterly current assets has increased by +$47.19 million (+20.32%).
- ORIC quarterly current assets is now -13.78% below its all-time high of $324.08 million, reached on March 31, 2024.
Performance
ORIC Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ORIC Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.0% | +20.3% |
3 y3 years | -28.4% | +20.3% |
5 y5 years | +386.2% | +20.3% |
ORIC Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -11.6% | +1.0% | -13.8% | +44.7% |
5 y | 5-year | -28.4% | +136.2% | -13.8% | +248.3% |
alltime | all time | -28.4% | +386.2% | -13.8% | +248.3% |
ORIC Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $279.43 M(-5.1%) |
Jun 2024 | - | $294.60 M(-9.1%) |
Mar 2024 | - | $324.08 M(+52.4%) |
Dec 2023 | $39.41 M(+7.3%) | $212.60 M(-8.5%) |
Sep 2023 | - | $232.24 M(-13.5%) |
Jun 2023 | - | $268.36 M(+38.9%) |
Mar 2023 | - | $193.16 M(-8.2%) |
Dec 2022 | $36.72 M | $210.46 M(+5.9%) |
Sep 2022 | - | $198.69 M(-14.9%) |
Jun 2022 | - | $233.53 M(-2.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $239.09 M(-0.6%) |
Dec 2021 | $58.12 M(+2427.0%) | $240.52 M(-17.9%) |
Sep 2021 | - | $292.85 M(+10.5%) |
Jun 2021 | - | $264.95 M(-5.4%) |
Mar 2021 | - | $280.10 M(-5.6%) |
Dec 2020 | $2.30 M(-43.8%) | $296.70 M(+56.9%) |
Sep 2020 | - | $189.06 M(-5.1%) |
Jun 2020 | - | $199.23 M(+148.3%) |
Mar 2020 | - | $80.23 M(-10.9%) |
Dec 2019 | $4.09 M(+36.0%) | $90.00 M |
Dec 2018 | $3.01 M | - |
FAQ
- What is ORIC Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual current assets year-on-year change?
- What is ORIC Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly current assets year-on-year change?
What is ORIC Pharmaceuticals annual total current assets?
The current annual current assets of ORIC is $212.60 M
What is the all time high annual current assets for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual total current assets is $296.70 M
What is ORIC Pharmaceuticals annual current assets year-on-year change?
Over the past year, ORIC annual total current assets has changed by +$2.14 M (+1.02%)
What is ORIC Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ORIC is $279.43 M
What is the all time high quarterly current assets for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly total current assets is $324.08 M
What is ORIC Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ORIC quarterly total current assets has changed by +$47.19 M (+20.32%)